TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hightide Therapeutics Inc ( (HK:2511) ) has provided an update.
HighTide Therapeutics, Inc. has announced a board meeting scheduled for March 28, 2025, to discuss and approve the audited annual results for the year ending December 31, 2024. This meeting is crucial for stakeholders as it will provide insights into the company’s financial performance and future strategies.
More about Hightide Therapeutics Inc
HighTide Therapeutics, Inc. operates in the pharmaceutical industry, focusing on the development of innovative therapies for metabolic and digestive diseases.
YTD Price Performance: -13.39%
Average Trading Volume: 615,853
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$545.7M
For an in-depth examination of 2511 stock, go to TipRanks’ Stock Analysis page.